MICHAEL SAVELLE: Open Payments
NPI 1568078483 · BARNESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,039 in 51 payments from 11 companies in 2025. Trend: 2023 $1,123 · 2024 $1,350 · 2025 $1,039
Food & beverage: $1,039
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $238 |
| PFIZER INC. | 12 | $228 |
| AstraZeneca Pharmaceuticals LP | 10 | $222 |
| Novo Nordisk Inc | 5 | $108 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $72 |
| Sumitomo Pharma America, Inc. | 2 | $41 |
| Lilly USA, LLC | 2 | $38 |
| Amgen Inc. | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
Products named: NURTEC ODT, ELIQUIS, AIRSUPRA, Ozempic, JARDIANCE, FARXIGA, BOTOX, VRAYLAR.
Industry payments across GA — which companies pay providers there.
